Literature DB >> 7835588

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.

M Durazzo1, T Philipp, F N Van Pelt, B Lüttig, E Borghesio, G Michel, E Schmidt, S Loges, M Rizzetto, M P Manns.   

Abstract

BACKGROUND/AIMS: Anti-liver-kidney microsomal (LKM) autoantibodies occur in a proportion of patients with chronic hepatitis C and D infections. Because of different immunofluorescence patterns, antibodies in hepatitis C and D were termed LKM-1 and LKM-3, respectively. The aim of the present study was to evaluate the different specificities of LKM-1 and LKM-3 antibodies.
METHODS: Forty-nine samples of LKM-1 sera and 16 samples of LKM-3 sera were studied for reactivity against rat and human liver microsomal proteins by immunofluorescence, enzyme-linked immunosorbent assay, and Western blot.
RESULTS: Thirty-four percent of the LKM-1 sera reacted with 50-kilodalton cytochrome P4502D6 in Western blot. In addition, a proportion of the sera recognized either a 59- or 70-kilodalton antigen, and 45% of the sera did not react in Western blot. Recently, the major LKM-3 antigen was identified as an autoepitope expressed on uridine diphosphate-glucuronosyltransferases (UGT). Seven LKM-3-positive sera reacted with recombinant rabbit family one UGT. None of the anti-LKM-1-positive hepatitis C sera reacted with UGT. Antibody reactivity against liver microsomal proteins in enzyme-linked immunosorbent assay ended when antigens were pretreated with sodium dodecyl sulfate, confirming that antibodies recognize conformational epitopes.
CONCLUSIONS: LKM-1 antibodies in hepatitis C are more heterogeneous and react with different antigens compared with LKM-3 antibodies in hepatitis D.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7835588     DOI: 10.1016/0016-5085(95)90074-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

Review 1.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 3.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

4.  Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.

Authors:  R Klein; U M Zanger; T Berg; U Hopf; P A Berg
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 5.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

6.  Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection?

Authors:  Marilena Durazzo; Alberto Premoli; Cataldo Di Bisceglie; Angela Bertagna; Emanuela Faga; Giampaolo Biroli; Chiara Manieri; Simona Bo; Gianfranco Pagano
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

7.  Helicobacter pylori seroprevalence in patients with autoimmune hepatitis.

Authors:  Marilena Durazzo; Rinaldo Pellicano; Alberto Premoli; Mara Berrutti; Nicola Leone; Antonio Ponzetto; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

8.  Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection.

Authors:  Rinaldo Pellicano; Giovanni Antonio Touscoz; Antonina Smedile; Mara Berrutti; Giorgio Saracco; Alessandro Repici; Antonio Ponzetto; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 9.  Overlap syndromes of autoimmune hepatitis: what is known so far.

Authors:  Marilena Durazzo; Alberto Premoli; Sharmila Fagoonee; Rinaldo Pellicano
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

10.  Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics.

Authors:  M Baeres; J Herkel; A J Czaja; I Wies; S Kanzler; E L R Cancado; G Porta; M Nishioka; T Simon; C Daehnrich; W Schlumberger; P R Galle; A W Lohse
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.